The Global ChemotherapyDevices Market, by Product (Catheter, Cannula, Pump, and Others), by EndUser (Hospitals, Clinics, and Home Care), and by Region (North America, LatinAmerica, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 10.9billion in 2017, and is projected to exhibit a CAGR of 7.7% over the forecastperiod (2018 - 2026).
Technological advancements incancer treatments such as chemotherapy and rising investment in cancer care arereducing the number of cancer deaths worldwide. According to the Cancer Journalfor Clinicians 2016 study, the number of cancer survivors continues to grow inthe U.S. due to increasing number of new cancer diagnoses resulting from agrowing and aging population. As per the same report, over 15.5 millionAmericans with a history of cancer were alive on January 1, 2016 and thisnumber is projected to reach 20.3 million by January 1, 2026. Chemotherapy ismost often administrated via a vein (intravenously) using devices such as catheterand ports. Long-term central venous access devices are essential for themanagement of cancer patients, as they minimize the discomfort of frequentvenipuncture and cannulation. A catheter reduce the number of times to insert aneedle in patient vein. According to the WHO 2017 report, in most upper andmiddle income countries, the chemotherapy dosage for some treatments and forpatients with metastatic diseases is done using implantable central venouscatheters or peripherally inserted central catheters (PICC).
* The sample copy includes: Report Summary, Table of Contents,Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2231
Manufacturers in the chemotherapydevices market are focused on technological advancements in devices. Forinstance, in May 2018, Advanced Chemotherapy Technologies announced developmentof an implant, about the size of a large coin for direct delivery of chemoagents into the pancreas. In 2017, RenovoRx received FDA approval forRenovoCath dual-balloon infusion catheter to include the delivery ofchemotherapeutics. Browse 24 Market Data Tables and 25 Figures spread through170 Pages and in-depth TOC on "Chemotherapy Devices Market, by Product(Catheter, Cannula, Pump, and Others), by End User (Hospitals, Clinics, andHome Care), and by Region (North America, Latin America, Europe, Asia Pacific,Middle East, and Africa) - Global Forecast to 2026"
Browse Research Report: https://www.coherentmarketinsights.com/market-insight/chemotherapy-devices-market-2231
Key Takeaways of the ChemotherapyDevices Market:
The global chemotherapy devicesmarket is expected to expand at a CAGR of 7.7% during the forecast period(2018–2026), owing to rising cancer incidence coupled with increasingconsumption of tobacco and alcohol, and rising geriatric population base
Among product, the pumps segmentis expected to generate significant revenue in 2018, due to high price ascompared to other products.
Major players operating in theglobal chemotherapy devices market include Advanced Chemotherapy Technologies,Baxter International, Becton, Dickinson Company, B. Braun, Fresenius Kabi,Halyard Health, ICU Medical, Moog Inc., Micrel Medical, Smiths Group, TerumoCorporation, and Zyno Medical
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2231
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offering action-readysyndicated research reports, custom market analysis, consulting services, andcompetitive analysis through various recommendations related to emerging markettrends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
